Genexine ranked among the top searched stocks for 13 days in the past month.


As of 12:30 PM on the 28th, Genexine is trading at 176,100 KRW, down 0.51% from the previous day. This represents a 49.24% increase compared to August 12. Genexine is known as a company specializing in the development of biopharmaceuticals.

Today, foreigners have sold a net 32,000 shares of Genexine, and institutions have sold a net 3,000 shares, according to provisional data. Over the past five days, individual investors have bought a net 461,769 shares, while foreigners and institutions have bought a net 21,156 shares and sold a net 147,520 shares, respectively.


On August 27, Genexine became a market issue with the news of confirmed efficacy of 'Interleukin-7' in treating COVID-19, rising 17.7%.





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing